Dear Client,
As part of our ongoing commitment to ensuring the security of your online trading experience, we would like to inform you of our protocol for addressing any suspicious activities observed on your trading account.
Should you notice any irregularities or suspect unauthorized access to your account, we kindly request that you take immediate action by following the steps outlined below:
Send an EmailPlease send an email to stoptrade@acml.infrom your registered email ID. In the email, briefly outline the suspicious activity you have observed.
Phone Call Alternatively, you can call us at 07965081981 Ext: 4 from your registered mobile number. This will enable us to address your concerns promptly.
When contacting us, please ensure you provide the following details:
By providing this information, you enable us to swiftly investigate and take appropriate measures to safeguard your account.
Your security and peace of mind are of utmost importance to us,and we appreciate your cooperation in maintaining the integrity of your trading account.
Nephrocare Health Services Ltd announced credit rating actions from India Ratings and India Ratings and Research (Ind-Ra) across various bank loan facilities and a term loan. India Ratings upgraded the Bank Loan Facilities - Long -term to IND AA-/Stable and the Bank Loan Facilities - Short -term to IND A1+ / IND AA- / Stable, reaffirmed the Short-Term Rating at IND A1+, and upgraded Bank Loan Facilities to IND AA- with a stable outlook; Ind-Ra upgraded bank loan facilities totaling 2,262.27, affirmed short-term ratings on bank loan facilities totaling 2,700.00, assigned a rating of IND AA-/Stable/IND A1+ to bank loan facilities of 506.63, and provided ratings for additional bank loan facilities of 650 (Citibank N.A.), 400 (HDFC Bank Limited), and 1,650 (Hongkong Shanghai Banking corporation), alongside a term loan of 68.9 from Asian Development Bank, all carrying the IND AA-/Stable/IND A1+ rating, with no other rating agencies or instruments mentioned.